CellWell record HH-513388
P143 - ECE_1310 - EDL6D an SHBG mimetic peptide: a new approach for treating the metabolic dysfunction-associated fatty Liver Disease
Anna Álvarez-Guaita; Beatriz Pérez-González; M. T. Salcedo Allende; Lidia Fuertes Rioja; Lorena Ramos Perez; Cristina Hernández; Rafael Simó Canonge; David M. Selva
European Journal of Endocrinology · 2026
In plain language
An SHBG-mimetic peptide reduced liver fat, lipogenic enzyme expression and early fibrosis markers in fructose-treated HepG2 cells and in mice with diet-induced fatty liver disease.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-513388
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.